Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00498654 · ClinicalTrials.gov registry record · Phase 2
Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects
A Phase 2 study, sponsored by Avant Immunotherapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 180
- Enrollment target
NCT00498654: Completed Phase 2 study, sponsored by Avant Immunotherapeutics.
NCT00498654 is a Phase 2 study that has completed, run by Avant Immunotherapeutics. The registered enrollment target is 180 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (35% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00498654, a Phase 2 study, has completed, sponsored by Avant Immunotherapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 180 participants
- Enrollment target
Study Summary
The purpose of this trial is to examine the safety and immunogenicity of Ty800 oral vaccine in healthy adult subjects.
Interventions
- BIOLOGICAL Ty800 (Salmonella typhi) Oral Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
What the finished NCT00498654 record still lists
NCT00498654 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (35% higher).
The record links to 0 conditions, and to 1 intervention - of which Ty800 (Salmonella typhi) Oral Vaccine is the first listed.
NCT00498654 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00498654 about?
NCT00498654 is a clinical study titled "Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects". The purpose of this trial is to examine the safety and immunogenicity of Ty800 oral vaccine in healthy adult subjects.
What is the current status of trial NCT00498654?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2007-07. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00498654?
The interventions under investigation include: Ty800 (Salmonella typhi) Oral Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00498654?
This trial is sponsored by Avant Immunotherapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00498654's enrollment target sits among peer trials
180 365th of 2000 higher than 1,610 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia